Needle biopsy for breast cancer diagnosis: A quality metric for breast surgical practice

摘要

Percutaneous needle biopsy (PNB) for breast tissue diagnosis has emerged as a quality metric for breast disease management In 2003, the National Comprehensive Cancer Network identified needle biopsy as "preferred" over surgical excision for breast diagnosis.1 In 2005, a multi-disciplinary international consensus conference concluded that PNB is the "optimal initial tissue-acquisition method and the procedure of choice for image-detected breast abnormalities."2(p588) More recently, the National Accreditation Program for Breast Centers established "palpation-guided or image-guided needle biopsy as the initial diagnostic approach rather than open biopsy" as one of 19 clinical management standards by which breast centers are measured.3(pe68) Thus, PNB represents an important transition in breast cancer management of specific interest to surgeons.